SCHEMBL8808231

SCHEMBL8808231

Clc1cc(-c2c(-c3ccccc3)nn3ccccc23)ccn1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.53
ADORA2A P29274 3/20 0.53
ADORA1 P30542 3/20 0.53
EGFR P00533 1/20 0.53
RAF1 P04049 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
ADORA2B P29275 1/20 0.53
GSK3B P49841 1/20 0.53
AKT1 P31749 1/20 0.48
IGF1R P08069 2/20 0.45
MAPK1 P28482 5/20 0.44
MAPK3 P27361 1/20 0.44
ADCY10 Q96PN6 1/20 0.40
PDE4B Q07343 2/20 0.37
PDE3A Q14432 1/20 0.37
PDE5A O76074 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14502354 0.81 AKT1 (0.65) MAPK14ADORA2AADORA1EGFRRAF1
SCHEMBL8810374 0.81 MAPK14 (0.50) MAPK14ADORA2AADORA1EGFRRAF1
SCHEMBL8810466 0.80 MAPK14 (0.78) MAPK14ADORA2AADORA1EGFRRAF1
SCHEMBL8808262 0.77 GSK3B (0.49) MAPK14ADORA2AADORA1EGFRRAF1
SCHEMBL5378766 0.76 MAPK14 (0.72) MAPK14ADORA2AADORA1EGFRRAF1
SCHEMBL8811450 0.76 MAPK14 (0.57) MAPK14ADORA2AADORA1EGFRRAF1
SCHEMBL7667628 0.74 PDE5A (0.62) MAPK14ADORA2AADORA1EGFRRAF1
SCHEMBL8807637 0.73 AKT1 (0.51) MAPK14ADORA2AADORA1EGFRRAF1
SCHEMBL8809320 0.73 AKT1 (0.54) MAPK14ADORA2AADORA1EGFRRAF1
SCHEMBL5391142 0.73 MAPK14 (0.62) MAPK14ADORA2AADORA1EGFRRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0379979-B1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1997-03-19 EP disclosed
US-5155114-A Treating or preventing renal toxicity, nephrosis, nephritis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-10-13 US disclosed
US-4985444-A Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-01-15 US disclosed
EP-0379979-A1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-01 EP disclosed